ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,993Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 134

$844K Total Retail Price of All Prescriptions

Rank: 9 out of 134

399 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 399 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 399 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 8,689 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LEVOTHYROXINE SODIUM 523 437 1 1
SIMVASTATIN 401 341 2 2
HYDROCODONE-ACETAMINOPHEN 361 196 S3 3 5
OMEPRAZOLE 291 235 4 3
AMLODIPINE BESYLATE 283 187 5 6
LISINOPRIL 256 185 6 4
FUROSEMIDE 244 212 7 7
ZOLPIDEM TARTRATE 226 130 8 15
LOSARTAN POTASSIUM 209 156 9 11
METFORMIN HCL 209 174 9 9
CITALOPRAM HBR 193 146 11 14
METOPROLOL TARTRATE 187 139 12 17
POTASSIUM CHLORIDE 187 175 12 10
WARFARIN SODIUM 179 121 14 8
TRIAMTERENE-HCTZ 155 132 15 40
CARVEDILOL 144 85 16 27
PREDNISONE 143 102 17 28
HYDROCHLOROTHIAZIDE 142 134 18 13
RENVELA 133 30 19 168
ALLOPURINOL 131 115 20 25
TRAMADOL HCL 122 99 21 22
VENLAFAXINE HCL ER 116 65 22 61
GABAPENTIN 116 76 22 12
PANTOPRAZOLE SODIUM 114 82 24 57
DIOVAN 113 79 25 55
ALENDRONATE SODIUM 110 91 26 21
ATORVASTATIN CALCIUM 108 98 27 18
CLONIDINE HCL 103 47 28 60
MELOXICAM 101 69 29 35
SENSIPAR 100 24 30 187
METOPROLOL SUCCINATE 99 64 31 16
GEMFIBROZIL 97 85 32 87
TRAZODONE HCL 93 62 33 23
PROMETHAZINE HCL 91 0 R 34 157
SERTRALINE HCL 90 47 35 24
PRAVASTATIN SODIUM 89 83 36 20
FENTANYL 79 49 S2 37 41
LYRICA 76 17 38 116
QUINAPRIL HCL 75 75 39 115
FLUOXETINE HCL 73 35 40 42
CLOPIDOGREL 72 53 41 52
CELEBREX 71 71 42 111
DIGOXIN 70 66 43 31
LANTUS SOLOSTAR 69 31 44 62
LANTUS 68 31 45 32
JANUVIA 68 56 45 77
PAROXETINE HCL 68 54 45 46
LOSARTAN-HYDROCHLOROTHIAZIDE 66 54 48 50
RANITIDINE HCL 64 49 49 48
NAMENDA 62 61 50 53
CYMBALTA 62 28 50 37
NEXIUM 60 18 52 54
ACTOS 60 56 52 81
IRBESARTAN 56 53 54 223
DILTIAZEM ER 56 56 54 91
RISPERIDONE 56 56 54 67
TAMSULOSIN HCL 55 51 57 26
DONEPEZIL HCL 54 41 58 30
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 0 58 127
FINASTERIDE 52 52 60 85
METOCLOPRAMIDE HCL 51 21 61 98
ATENOLOL 50 34 62 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.